|
|
We evaluated the therapeutic effect of non-specific immunotherapy with Histamine-
gammahlobulin in 60 patients. Among them 22 patients were chronic respiratory group patients who
were under 2 years of age and suffered from frequent respiratory tract infections, and 38 patients were
as follows:
1) Excluding the patients who received 9 weeks therapy for the test period, the mean duration of
Histamine-gammaglobulin therapy in the chronic respiratory... |
